Biotech Investor Relations Blog

Home/Biotech Investor Relations Blog/

An Overview of COVID-19 and the Emerging Potential Treatment Landscape

Introduction

The 2019 Novel Coronavirus Disease (COVID-19) epidemic has roiled equity markets as recent headlines highlight disease spread outside of the initial epicenter in Wuhan, China. We reviewed the scientific / medical literature to provide an evidence-based summary of what is known about this outbreak, how it compares to others in recent memory and potential therapies […]

By |2020-03-05T17:42:49-04:00March 5th, 2020|Biotech Investor Relations|Comments Off on An Overview of COVID-19 and the Emerging Potential Treatment Landscape

Proactively Managing Communications Through Global Crises

The evolving coronavirus crisis has dominated news coverage and has gripped global markets in recent weeks. While a majority of the attention has rightly focused on diagnosis, containment, and treatment, there are growing questions of the longer-term impact of this crisis on […]

By |2020-02-06T15:55:53-04:00February 6th, 2020|Corporate Communications|Comments Off on Proactively Managing Communications Through Global Crises

Guidelines for IR Communications

As we look towards a new year and a fresh start, we are also thinking of how to start the year right with messaging.  Here are a few tips to keep in mind and practice when communicating with Wall Street:

Be forthright. Build […]

By |2019-12-19T15:43:27-04:00December 18th, 2019|Biotech Investor Relations|Comments Off on Guidelines for IR Communications

LifeSci Partners Launches Business Development and Market Analytics Offering, LifeSci Strategic Partnering and Analytics

NEW YORK, August 14, 2018 (GLOBE NEWSWIRE) – LifeSci Partners today announced the launch of its newest division, LifeSci Strategic Partnering and Analytics, focused on supporting partnering and strategic consulting activities for clients exclusively within the life sciences. Strategic partnering activities encompass facilitating in- and out-licensing transactions, R&D collaborations, as well as other strategic […]

By |2018-08-27T16:02:53-04:00August 14th, 2018|LifeSci News|Comments Off on LifeSci Partners Launches Business Development and Market Analytics Offering, LifeSci Strategic Partnering and Analytics

ProQR Announces Presentations on Programs in Ophthalmology at Conferences in July

LEIDEN, the Netherlands, July 12, 2018 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced upcoming presentations at the International Symposium on Usher Syndrome (USH2018) and the Ophthalmology Innovation Summit (OIS) Retina conferences.

By |2018-07-12T08:36:24-04:00July 12th, 2018|LifeSci in the Press|Comments Off on ProQR Announces Presentations on Programs in Ophthalmology at Conferences in July

LifeSci Partners Launches New Executive Search Offering, LifeSci Search

NEW YORK, July 10, 2018 (GLOBE NEWSWIRE) — LifeSci Partners, a life sciences-focused consultancy, today announced the launch of LifeSci Search, a global recruitment service. LifeSci Search will operate exclusively in the biotechnology, pharmaceutical and healthcare sectors, and was founded to address the broad deficiencies in the life sciences […]

By |2018-08-27T16:25:09-04:00July 10th, 2018|LifeSci News|Comments Off on LifeSci Partners Launches New Executive Search Offering, LifeSci Search

6 Ways to Benefit from a Non-Deal Roadshow

pasted image 0 9It should be obvious.

To keep and gain happy and loyal investors, you need to cultivate healthy, active relationships and open communication. But all too often, many public companies can lose sight of this if they aren’t careful.

There are many ways, however, to keep relations […]

By |2019-12-19T16:05:04-04:00February 14th, 2018|Non-deal Roadshows|Comments Off on 6 Ways to Benefit from a Non-Deal Roadshow